{"id":58112,"date":"2023-09-27T01:05:22","date_gmt":"2023-09-26T23:05:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/"},"modified":"2023-09-27T01:05:22","modified_gmt":"2023-09-26T23:05:22","slug":"lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/","title":{"rendered":"Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners"},"content":{"rendered":"
\n

\nMaker of continuous real-time metabolic analysis systems experiences growing demand. Will build capacity for new product offerings, manufacturing, and global sales and marketing.<\/i><\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

ATLANTA–(BUSINESS WIRE)–Lucid Scientific, a life science instruments company that manufactures Resipher, announced the completion of a $7 million Series A financing led by IAG Capital Partners. Additional participants include Lucid\u2019s original investor base, the Georgia Research Alliance\u2019s Venture Fund, and Dynamk Capital, bringing Lucid\u2019s total funding to date to approximately $13 million. Proceeds from this round will help the company aggressively expand production, sales and marketing, as well as broaden new product advancements. IAG Venture Partner Dr. Ehsan Jabbarzadeh will join Lucid\u2019s Board of Directors.<\/p>\n

\n\u201cWe are thrilled to partner with Lucid Scientific to market a ground-breaking technology for real-time analysis of cell metabolomics,\u201d said Dennis Sacha of IAG Capital Partners. \u201cThe platform will provide scientists with a powerful tool to understand dynamic biological responses and the discovery of cures for most difficult diseases.\u201d<\/p>\n

\nThe financing accelerates exceptional momentum for Lucid, and for their upcoming launch of new Resipher hardware and consumable products this fall. Resipher provides researchers with valuable insights into cellular metabolism that are of central importance for a wide range of therapeutic applications and drug safety considerations. Resipher converts standard cell culture plates into smart readers that detect and report metabolic changes in real-time. This data significantly accelerates the cell culture research cycle by bridging the gap between performing experiments and gaining actionable insight.<\/p>\n

\n\u201cThis financing enables Lucid to continue improving the Resipher line of products for researchers and drug discovery teams whose work directly impacts human health,\u201d said Dr. Walker Inman, CEO of Lucid Scientific. \u201cWe are excited to have Ehsan and IAG join our team, as they provide a wealth of experience and help position Lucid to achieve our goals.\u201d<\/p>\n

\nLucid Scientific<\/b> is a life science instruments company working to accelerate drug discovery and fundamental biological research by providing systems for real-time cellular analysis. Headquartered in Atlanta, GA at the Advanced Technology Development Center (ATDC), Lucid is supported by public and private sources including IAG Capital Partners, Dynamk Capital and the GRA Venture Fund. lucidsci.com<\/a><\/p>\n

\nIAG Capital Partners <\/b>is based in Charleston, South Carolina and partners with innovative leaders to build companies that will change the world. iagcapitalpartners.com<\/a><\/p>\n

\nDynamk Capital <\/b>is a growth equity and venture capital firm focused on life sciences industrials. Dynamk’s investment strategy is centered on identifying companies developing disruptive technologies, tools, and services that enable the full biopharma continuum across discovery, development, and manufacturing of biotherapeutics, including cell & gene therapies and vaccines. dynamk.vc<\/a><\/p>\n

\nGRA Venture Fund <\/b>is a public-private venture capital fund investing in research-driven, Georgia-based startup companies. The Fund makes seed, early-stage and mid-stage investments in companies. Fund investors are the State of Georgia, private individuals, corporations and foundations. graventurefund.org<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\ninfo@lucidsci.com<\/a>
+1-617-237-0665<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Maker of continuous real-time metabolic analysis systems experiences growing demand. Will build capacity for new product offerings, manufacturing, and global sales and marketing. ATLANTA–(BUSINESS WIRE)–Lucid Scientific, a life science instruments company that manufactures Resipher, announced the completion of a $7 million Series A financing led by IAG Capital Partners. Additional participants include Lucid\u2019s original investor … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58112","6":"format-standard","7":"category-industry"},"yoast_head":"\nLucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Maker of continuous real-time metabolic analysis systems experiences growing demand. Will build capacity for new product offerings, manufacturing, and global sales and marketing. ATLANTA–(BUSINESS WIRE)–Lucid Scientific, a life science instruments company that manufactures Resipher, announced the completion of a $7 million Series A financing led by IAG Capital Partners. Additional participants include Lucid\u2019s original investor ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-26T23:05:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230926790900\/en\/1900056\/21\/home_carousel_multiple_resipher.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners\",\"datePublished\":\"2023-09-26T23:05:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/\"},\"wordCount\":492,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230926790900\\\/en\\\/1900056\\\/21\\\/home_carousel_multiple_resipher.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/\",\"name\":\"Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230926790900\\\/en\\\/1900056\\\/21\\\/home_carousel_multiple_resipher.jpg\",\"datePublished\":\"2023-09-26T23:05:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230926790900\\\/en\\\/1900056\\\/21\\\/home_carousel_multiple_resipher.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230926790900\\\/en\\\/1900056\\\/21\\\/home_carousel_multiple_resipher.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/","og_locale":"en_US","og_type":"article","og_title":"Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners - Pharma Trend","og_description":"Maker of continuous real-time metabolic analysis systems experiences growing demand. Will build capacity for new product offerings, manufacturing, and global sales and marketing. ATLANTA–(BUSINESS WIRE)–Lucid Scientific, a life science instruments company that manufactures Resipher, announced the completion of a $7 million Series A financing led by IAG Capital Partners. Additional participants include Lucid\u2019s original investor ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/","og_site_name":"Pharma Trend","article_published_time":"2023-09-26T23:05:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230926790900\/en\/1900056\/21\/home_carousel_multiple_resipher.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners","datePublished":"2023-09-26T23:05:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/"},"wordCount":492,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230926790900\/en\/1900056\/21\/home_carousel_multiple_resipher.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/","url":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/","name":"Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230926790900\/en\/1900056\/21\/home_carousel_multiple_resipher.jpg","datePublished":"2023-09-26T23:05:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230926790900\/en\/1900056\/21\/home_carousel_multiple_resipher.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230926790900\/en\/1900056\/21\/home_carousel_multiple_resipher.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lucid-scientific-secures-7-million-series-a-financing-led-by-iag-capital-partners\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58112"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58112\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}